Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1992
05/05/1992US5110603 Bathing preparation for colloidal material
05/05/1992US5110602 Solution or suspension in middle chain glyceride to inhibit degradation by digestive enzymes
05/05/1992US5110600 Method of treating viral infections with amino acid analogs
05/05/1992US5110599 Accuracy, uniformity
05/05/1992US5110583 Peroxy acids composition for oral treatment
05/05/1992CA1300313C2 Amino acid derivatives
05/05/1992CA1300170C Process for intermediates to leukotriene antagonists
05/05/1992CA1300169C Process for intermediates to leukotriene antagonists
05/05/1992CA1300162C2 Benzamide, preparation process and therapeutic use
05/05/1992CA1300161C Carboxamido dihydrobenzofuran and chroman derivatives, their preparation process and their use as neuroleptics
05/05/1992CA1300157C Dihydropyridine compounds having unique pharmacological effects, and the process for producing them
05/05/1992CA1300154C N-substituted piperid-4-yl benzamide compounds and 1-substituted-4-amino-piperidine compounds
05/05/1992CA1300153C 2-pyridylacetic acid derivative, preparation process thereof and pharmaceutical composition containing the same
05/05/1992CA1300152C Diacylderivatives of glycerylphosphorylcholine having therapeutical activity, a process for their preparation and related pharmaceutical compositions
05/05/1992CA1300151C 1,3-dihydro-6-¬1-cyano-1-isopropyl-n-phenethyl-n-methyl- aminoalkyl|-7-hydroxy-furo-(3,4-c)-pyridine derivatives
05/05/1992CA1300150C 1,3-dihydro-6-aminomethyl-7-hydroxy-furo-(3,4-c)-pyridine derivatives
05/05/1992CA1300149C 1,3-dihydro-6-(1-hydroxy-2-dimethylaminomethyl-allyl)-7- hydroxy-furo-(3,4-c)-pyridine derivatives
05/05/1992CA1300148C 1,3-dihydro-6-(1-hydroxy-2-dimethylaminomethyl-allyl)-7- hydroxy-furo(3,4-c)-pyridine derivatives
05/05/1992CA1300146C 12b-substituted 1-hydroxymethyl-octahydroindolo¬2,3-a|- quinolizine derivatives, process for the preparation and pharmaceutical compositions containing them
05/05/1992CA1300145C Taurine-type compounds
05/05/1992CA1300139C Piperazinyl-heterocyclic compounds
05/05/1992CA1300138C Oxabicycloheptane derivatives
05/05/1992CA1300135C Substituted quinoxalines
05/05/1992CA1300133C Benzimidazolesulfonamides and imidazopyridinesulfonamides; process for preparing the same and their use as therapeutic agents
05/05/1992CA1300131C Antibiotics retinoid esters, their preparation process and pharmaceutical and cosmetical compositions containing them
05/05/1992CA1300125C Cephalosporin derivatives
05/05/1992CA1300024C Agent having renal function-improving effect and diuretic effect
05/05/1992CA1300021C Transdermal therapeutic systems for active ingredient combinations
05/05/1992CA1300020C Method for treating male sexual dysfunction
05/05/1992CA1300019C Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
05/05/1992CA1300018C Antigestagens for shifting the endometrial maturation
05/05/1992CA1300017C Composition for preventing osteoporosis
05/05/1992CA1300015C Compositions comprising 1-substituted azacycloalkanes
05/03/1992WO1992007558A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
05/03/1992WO1992007557A1 Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c
05/03/1992CA2488792A1 Antisense oligonucleotides for treatment of cancer
05/03/1992CA2072889A1 Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c
05/03/1992CA2072884A1 1,4-bis-(amino-hydroxyalkylamino)-anthraquinones for inhibiting protein kinase c
05/03/1992CA2054648A1 1-(2-arylethyl)-pyrrolidines
05/02/1992WO1992007867A1 Polysubstituted benzimidazoles as antiviral agents
05/02/1992WO1992007866A1 Anthracycline analogues bearing latent alkylating substituents
05/02/1992WO1992007585A1 The use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
05/02/1992CA2100098A1 Polysubstituted benzimidazoles as antiviral agents
05/02/1992CA2094154A1 Use of antibodies to tnf or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
05/02/1992CA2054653A1 Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use therefor
05/02/1992CA2054529A1 Synergism of hiv reverse transcriptase inhibitors
05/02/1992CA2054526A1 Controlled release formulations
05/02/1992CA2054430A1 3-oxy-substituted isoxazolines, process for their preparation and their use for combating endoparasites
05/01/1992WO1992007856A1 SUBSTITUTED INDOLIZINO[1,2-b]QUINOLINONES
05/01/1992WO1992007853A1 Certain imidazoquinoxalines; a new class of gaba brain receptor ligands
05/01/1992WO1992007851A1 PROCESS FOR THE PREPARATION OF 1β-ETHYL-1α-(HYDROXYMETHYL)-1,2,3,4,6,7,12,12bα-OCTAHYDRO-INDOLO[2,3-a]QUINOLIZINE AND NOVEL INTERMEDIATES
05/01/1992WO1992007850A1 Novel compounds
05/01/1992WO1992007839A1 Thiazolidinedione derivatives
05/01/1992WO1992007561A1 Antiphlogistic and analgesic gel preparation
05/01/1992CA2095219A1 Substituted indolizino[1,2-b]quinolinones
05/01/1992CA2095147A1 Compounds
05/01/1992CA2095146A1 Thiazolidinedione derivatives
05/01/1992CA2071878A1 Process for the preparation of 1.alpha.-ethyl-1 -(hydroxymethyl)-1,2,3,4,6,7,12,12ba-octahydro-indolo¬2,3- a|quinolizine and novel intermediates
05/01/1992CA2054594A1 Indole-and benzimidazole-substituted imidazole and benzimidazole derivatives
05/01/1992CA2054544A1 Process for the preparation of piperazine derivatives
05/01/1992CA2054475A1 Composition with antierythemal activity and cosmetic use thereof
05/01/1992CA2054465A1 Thienoimidazole derivatives, their production and use
05/01/1992CA2054134A1 Method and composition for the protection of a metabolic recovery of ischemic cardiac tissue
05/01/1992CA2052246A1 Lithium treatment
04/1992
04/30/1992WO1992007590A1 Transdermal contraceptive formulations, methods and devices
04/30/1992WO1992007073A1 Osteogenic peptides
04/30/1992WO1992007065A1 Modified ribozymes
04/30/1992WO1992006996A1 Peptides containing substituted 1,4-diamines as transition-state inserts
04/30/1992WO1992006978A1 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
04/30/1992WO1992006975A1 1'-aminospiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones and analogs thereof useful as aldose reductase inhibitors
04/30/1992WO1992006974A1 Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors
04/30/1992WO1992006973A1 Indole derivatives
04/30/1992WO1992006967A1 Therapeutically useful 2-aminotetralin derivatives
04/30/1992WO1992006960A1 Piperazine derivatives
04/30/1992WO1992006957A1 2-phenyl-and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties
04/30/1992WO1992006948A1 Bi-aromatic compounds and their use in human and veterinary medecine and in cosmetic preparations
04/30/1992WO1992006713A1 Pharmaceutical composition containing an ace inhibitor and an inhibitor of thromboxane a2 activity for treating nephropathies
04/30/1992WO1992006702A1 A method for transplanting cells into the brain and therapeutic uses therefor
04/30/1992WO1992006700A1 Topical preparation and method for suppression of skin eruptions caused by herpes simplex virus
04/30/1992WO1992006695A1 Proanthocyanidin polymers having antiviral activity and methods of obtaining same
04/30/1992WO1992006692A1 Composition for therapeutic, prophylactic or diagnostic use in connection with infections
04/30/1992WO1992006690A1 Treatment of non-inflammatory and non-infectious bowel disorders
04/30/1992WO1992006688A1 New medical use for a certain indole derivative and pharmaceutical composition containing it
04/30/1992WO1992006685A1 Enhancement of cellular accumulation of lipophilic cationic organometallic compounds by reduction of intramembrane potential
04/30/1992WO1992006684A1 A new use of enprostil
04/30/1992WO1992006683A1 Aryl and heteroaryl compounds having anti-retrovirus activity
04/30/1992WO1992006682A1 Methods of treating osteoporosis, increasing bone mineral content and preventing the occurrence of compression fractures in a mammal
04/30/1992WO1992006679A1 A method for drug formulation and a pharmaceutical composition
04/30/1992WO1992003412A3 Benzamide derivatives
04/30/1992WO1991019725A3 Heterocyclic anthracyclione and anthracycline analogs
04/30/1992WO1991018866A3 1,4-diamino-2,3-dihydroxybutanes
04/30/1992DE4034090A1 Treating disease caused by normal or modified lipoprotein(s)
04/30/1992CA2094139A1 Aryl and heteroaryl compounds having anti-retrovirus activity
04/30/1992CA2093527A1 New medical use for a certain indole derivative and pharmaceutical composition containing it
04/30/1992CA2091883A1 Transdermal contraceptive formulations, methods and devices
04/30/1992CA2071940A1 Piperazine derivatives
04/30/1992CA2054347A1 Process for preparing epoxy-heparides, the products obtained and pharmaceutical compositions containing them
04/29/1992EP0483105A1 Solid drug-delivery devices employing fatty acid esters or fatty alcohol ethers of alkanediols as percutaneous absorption enhancers
04/29/1992EP0483077A2 A method for carrying out the synthesis of a contraceptive and menstrual cycle controlling drug having oncostatic, antikinetosic, preventive and therapeutic properties for treatment of mammary tumours and melanomas.
04/29/1992EP0483070A2 Nutritionally complete feeding composition containing hydrolysed soluble fiber